AFYREN announces the signing of two strategic contracts for AFYREN NEOXY in the nutrition and health markets
- Sales accounting for 60% of the AFYREN NEOXY factory’s projected acid production at full capacity are secured1
- Food and feed markets are growing more than 6% annually2
Clermont-Ferrand/Lyon, December 21, 2021 7:30 a.m. CET – AFYREN, a greentech company that offers manufacturers natural, low-carbon products created with technology based on natural micro-organisms, has signed two strategic contracts for the long-term supply of biobased ingredients by AFYREN NEOXY to two major players in the nutrition (human and animal) and health markets.
The two contracts were established with major companies that are leaders in their sectors:
- the first is for the manufacture of high quality food ingredients, particularly for the confectionery, meat, chocolate and dairy markets
- the second is for the manufacture of nutritional and health products for animals.
The markets addressed by these partners have significant growth potential amid increasing consumer demand for natural and bio-based products. AFYREN is responding to these trends by ensuring a local supply chain for the raw materials used by its AFYREN NEOXY plant and through its innovative proprietary technology platform.
Data Bridge Market Research analysis shows that the animal nutrition market is expected to grow at a compound annual growth rate of 6.5% for the 2021 to 2028 period. The human nutrition market is growing at a similar rate, according to a report from Wellness Creative Co.
Taking into account these deals, 60% (by volume) of the organic acid output to be produced by the AFYREN NEOXY plant is already pre-sold.
Nicolas SORDET, AFYREN’s CEO, said: “In the wake of the recently announced partnership with ENNOLYS, these two new agreements underscore the attractiveness of our products and our unique positioning — based on a circular economy and a zero-industrial-waste approach. The markets we will be addressing are growing steadily and are experiencing significant demand for sustainable and biobased ingredients, driven by consumers who are seeking healthier and more responsible lifestyles. By ensuring the supply of these two leading players in animal nutrition and human food, we are taking additional steps to secure future revenue for AFYREN NEOXY while positioning ourselves as a leading supplier of biobased organic acids at the European level. This allows us to continue to guarantee a successful start for this first plant and approach its ramp-up with confidence.”
1 Excluding fertilizer production already pre-sold at 100%
2 https://www.wellnesscreatives.com/nutrition-industry-statistics/
https://www.databridgemarketresearch.com/reports/global-animal-nutrition-market
Last news
Confirming the relevance of AFYREN’s business model and advancing the industrial production ramp-up
News post Press release
AFYREN announces the resumption of production at its plant after the successful technical shutdown
News post Press release
A new financial analyst initiates coverage of the AFYREN stock with a positive recommendation
News post Press release Concrete progress in industrial ramp-up: notable increase in sales in the first half of 2026
News post Press release
AFYREN’s impact-driven bioeconomy model confirmed by B Corp™ certification
News post Press release AFYREN receives €3 million grant from the Grand Est Region through the European Fair Transition Fund
News post Press release
Mass balance versus segregated bioeconomy: the inevitable cohabitation?
Publication AFYREN announces 2025 full-year financial results and the full takeover of its AFYREN NEOXY biorefinery
News post Press release
AFYREN obtains ISO 9001 certification, a globally acknowledged standard of rigor and performance, for its AFYREN NEOXY plant
News post Press release
Green Chemistry or Bio-Based Chemistry? Mind the confusion
Publication